SCHEMBL8091960

SCHEMBL8091960

COc1ccc(NC(=O)NCc2cc([N+](=O)[O-])cc3nc(OC)c(OC)nc23)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.51
MEN1 O00255 7/20 0.48
KMT2A Q03164 7/20 0.48
ALDH1A1 P00352 2/20 0.48
PKM P14618 2/20 0.48
PTPN1 P18031 1/20 0.47
PTPN6 P29350 1/20 0.47
MAPT P10636 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 1/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
NAMPT P43490 4/20 0.45
HSP90AA1 P07900 1/20 0.45
PAX8 Q06710 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
SGK1 O00141 1/20 0.45
HDAC1 Q13547 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8090408 0.82 KMT2A (0.41) ALOX5MEN1KMT2AALDH1A1PKM
SCHEMBL8085722 0.79 ALDH1A1 (0.42) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL8086966 0.78 ALDH1A1 (0.39) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL8078916 0.77 TRPV1 (0.48) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL8086955 0.77 TRPV1 (0.37) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL8078887 0.75 POLB (0.41) ALOX5MEN1KMT2AALDH1A1PKM
SCHEMBL8078908 0.74 MAPT (0.45) MEN1KMT2AALDH1A1PKMMAPT
SCHEMBL8090421 0.74
SCHEMBL6648213 0.73 CDC25C (0.36) ALOX5MEN1KMT2AALDH1A1MAPT
SCHEMBL8086968 0.73 CTSB (0.43) KMT2AALDH1A1PKMMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080743-A AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS NOVARTIS AG (CH) 2000-06-27 US disclosed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP disclosed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO disclosed